TrialDrug design, development and therapy2016

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.

Su-Jin Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.